Hip fractures generally occur in those aged approximately 80 yr in association with a fall. Blood loss from the fracture varies depending on the exact site and degree of displacement and comminution of the fracture, from a few millilitres to over 1 litre. Recent randomized studies on small numbers of patients using invasive cardiac monitoring have suggested that many of these patients are hypovolaemic at the time of surgery. 1±3 Correction of this hypovolaemia was best achieved by colloid solution rather than crystalloid and resulted in improved haemodynamic parameters, 1 2 and a tendency to a reduced hospital stay. 2 3 This study aimed to see if we could demonstrate any bene®ts from using a colloid solution given preoperatively to a larger number of patients in the usual clinical setting without the availability of intensive intraoperative monitoring.
Methods
Between April 1999 and January 2002, 398 patients presenting with a hip fracture, which was to be treated operatively at Peterborough District Hospital, were randomized to receive before surgery either 500 ml of normal saline or 500 ml of gelatin (Gelofusine, Braun Medical Ltd) preoperatively. Each of these solutions were provided in identical containers enclosed in opaque plastic and then numbered sequentially by the hospital pharmacy department. Randomization was achieved when the next numbered study¯uid was administered. Neither the patients nor the attending physicians were aware which solution was administered. No patient required un-blinding of the studȳ uid. All patients also received a standard i.v.¯uid regime of saline started at the time of admission in the emergency department at a rate of 1 litre every 8±12 h. The exclusion criteria were those patients whose hip fracture was being treated conservatively, those with clinical signs of congestive cardiac failure, and those in which it was not possible to obtain informed consent from the patient or the assent of the next of kin. Care programmes for all patients were identical and once entered in the study all patients received one of the study¯uids. Approval for the study was obtained from Peterborough and Fenland Local Research Ethics Committee.
Patients details recorded included age, sex, living in their own home (as opposed to institutional care), American Society of Anesthesiologists (ASA) grade, Mental test score, 4 mobility score, 5 type of anaesthesia used (general or regional), type of fracture (intracapsular or extracapsular), and type of surgery (arthroplasty or internal ®xation). The mental test score is a series of 10 simple questions on recall and orientation. The mobility score provides an estimate of the patient pre-fracture mobility, from being able to walk and undertake shopping unaided (score 9), through to being bedridden (score 0). For the ®rst 204 patients entered in the study the volume of preoperative, intraoperative, and postoperative (up to 5 days) i.v.¯uids was recorded. Recording of these data was discontinued after the ®rst 204 cases as it was time consuming to record and analysis of the data revealed no apparent difference between groups.
All patients were treated surgically with standard operative monitoring (intermittent arterial pressure, continuous ECG, pulse oximetry, capnography, and inhalation agent monitoring for general anaesthetic cases), but no invasive monitoring (arterial line, central venous pressure, or oesophageal Doppler ultrasonography). All surviving patients were followed until 1 yr from injury with no patient being lost to follow-up.
The primary outcome measure was mortality with secondary outcome measures of hospital stay, intraoperative decrease in arterial pressure, and medical complications. A decrease in arterial pressure was de®ned as a decrease of greater than 40 mm systolic from the preoperative value recorded on the theatre checklist chart. The criteria for the medical complications were: myocardial infarction±chest pain, raised enzymes and ECG changes; congestive cardiac failure±clinical signs requiring diuretic therapy; cerebrovascular accident±CT con®rmation of clinical signs of hemiplegia; deep vein thrombosisÐcon®rmed by ultrasound venography; and pulmonary embolismÐcon®rmed by post-mortem, isotope scanning or CT.
The study was limited to 396 patients when the two trial solutions used for the study ceased to be made by the manufacturer in identical packaging. Statistical analysis between groups was with the Fisher exact test for binary variables and the un-paired t-test for continuous variables. A P-value of less than 0.05 was considered statistically signi®cant. Mortality difference was studied with the logrank test for equality of survivor functions throughout the whole trial and Kaplan±Meier survival curves were plotted. Table 1 gives the characteristics of the patients. None of the differences between the two groups were statistically signi®cant. Figure 1 shows the mortality for the two groups. The log-rank test for equality of survivor functions showed no statistically signi®cant difference between groups (Pvalue=0.6). Table 2 gives the outcomes for the two groups. None of the differences between groups were statistically signi®cant. Subgroup analysis for the different fracture types (intracapsular vs extracapsular) or general vs spinal anaesthesia showed no statistically signi®cant difference in the outcome measure of mortality or length of hospital stay between groups. No adverse effects from the gelatin infusion occurred.
Results

Discussion
There have been three recent randomized studies on¯uid resuscitation for hip fracture patients, all using small numbers of patients and invasive cardiac monitoring.
1±3
Two of these, 2 3 have been summarized in the Cochrane review on the topic. 6 Sinclair and colleagues 2 studied 40 patients having hip fracture surgery under general anaesthesia. Patients were randomized to either conventional intraoperative¯uids or repeated colloid¯uid challenges. Haemodynamics were monitored using oesophageal Doppler ultrasonography. Those in the¯uid challenge group received approximately 750 ml more colloid during surgery and 300 ml less crystalloid. Those allocated to colloid challenges had a reduced length of hospital stay. Venn and colleagues 3 in a study of 90 hip fractures, randomized patients to`normal care', oesophageal Doppler or central venous pressure monitoring. They reported a reduced hospital stay for those allocated to¯uid challenges with either CVP or oesophageal Doppler monitoring. Marhofer and colleagues 1 measured haemodynamics with pulmonary artery and arterial catheters in 24 patients randomized to receive either 500 ml of 6% hetastarch or 1500 ml of Ringer's lactate solution. At the time of surgery under spinal anaesthesia, haemodynamic impairment was reduced in those patients receiving the hetastarch. None of these studies followed patients beyond hospital discharge or assessed functional outcomes.
In contrast to these ®ndings, a systematic review of the use of crystalloid vs colloid solutions for critically ill patients 7 identi®ed 37 randomized trials involving 1622 patients. There was a tendency to an increased mortality in those allocated to receive colloid solution. There have been no previous randomized studies using protocol-guided i.v.
uid therapy without invasive monitoring techniques in hip fracture patients. The present study also used patients having either general or regional anaesthesia, which was not possible for the studies of Sinclair 2 and Venn. 3 Spinal anaesthesia may be associated with a marginally lower early mortality for hip fracture patients but has no effect on longterm outcomes. 8 Our study was not able to demonstrate that the inclusion of a ®xed volume of 500 ml of colloid solution to the preoperative¯uid regime had any demonstrable effect on either mortality or hospital stay, although there was a tendency to shorter total hospital stay (P=0.067) for those allocated to the colloid group (Table 2) . This result may therefore have become signi®cant if a larger number of patients had been included in the study. Nor were we able to Preoperative saline vs gelatin for hip fracture patients demonstrate any bene®ts for subgroups of patients. In our study, we gave the colloid preoperatively but it may be that to be effective the colloid has to be given during surgery as in the studies of Sinclair 2 and Venn. 3 It is also possible that a future study would demonstrate that more invasive investigation of patients before or during surgery would be able to identify a sub-group of patients in whom colloid therapy or a more precise control of¯uid balance or vasopressor use would be of bene®t.
